Global Cord Blood Banking Services Market -2024-2031
Global Cord Blood Banking Services Market reached US$ YY billion in 2023 and is expected to reach US$ YY million by 2031 growing at a CAGR of YY% during the forecast period 2024-2031.
Cord blood banking is the process of collecting cord blood and extracting and cryogenically freezing its stem cells and other cells of the immune system for potential future medical use. Cord blood is the blood that remains in the umbilical cord and placenta post-delivery.
Cord blood has an abundance of stem cells and immune system cells, and the medical uses of these cells have been expanding at a rapid pace. As these cells help the body re-generate tissues and systems, cord blood is often referred to as regenerative medicine. Stem cells from cord blood rarely carry any infectious diseases and are half as likely to be rejected as adult stem cells.
Market Dynamics
Increasing prevalence of genetic disorders
The increasing number of genetic disorders and cancer cases acts as a significant driver for market growth. Also, many significant companies play a major role in the advancements of the market by launching new cord blood bank services.
For instance, according to the National Institute of Health Report 2023, a multisystem condition, sickle cell disease (SCD) affects 1 in 500 African Americans and is the most common hereditary disease in the US. Every year, 300,000 newborns are born with sickle cell anemia, and approximately 1 in 12 African Americans carry the autosomal recessive trait.
Additionally, according to the Leukemia and Lymphoma Society, approximately every 3 minutes, one person in the US is diagnosed with leukemia, lymphoma, or myeloma. An estimated 1,629,474 people in the United States (US) are living with or in remission from leukemia, lymphoma, myeloma, and myelodysplastic syndromes (MDS).
Furthermore, the global cord blood banking services market is driven by various factors like rising awareness regarding cord blood banks, increasing collaborations, and investments are expected to drive the market in the forecast period.
High cost associated with cord blood banking
High costs regarding cord blood storage can hamper the market growth. For instance, cord blood banking in the United States for private banking is between $1350 and $2350 for collecting, testing, and registering. Also, $100 to $175 in annual storage and maintenance fees.
For more details on this report – Request for Sample
Segment Analysis
The global cord blood banking services market is segmented based on bank type, component, application, end users and region.
The cancers segment accounted for approximately 53.4% of the market share
Stem cells from cord blood have been shown to help treat many life-threatening conditions like cancer. The cancer segment is expected to hold the largest market share over the period forecast owing to increasing cases of leukemia and investments by the key players.
For instance, the American Cancer Society 2023, estimates that leukemia in the United States 2023 are about 59,610 new cases of leukemia and 23,710 deaths from leukemia. Also, about 20,380 new cases of acute myeloid leukemia (AML).
Additionally, in April 2023, ImmuneBridge raised $12 Million to source natural killer cell therapy from umbilical cord blood that can be used for cancer treatment. Hence, owing to the above factors, there is an increased demand for cord blood banking services.
Geographical Analysis
North America is expected to hold a significant position in the global cord blood banking services market share
The global cord blood banking services market is segmented into North America, Europe, Asia Pacific, South America, Middle East and Africa.
North America has maintained a significant market proportion due to factors such as the increasing prevalence of genetic disorders, healthcare expenditure, and rising awareness regarding cord blood banks, this trend is anticipated to continue throughout the forecast period.
For instance, in July 2021, America declared July as ""Cord Blood Awareness Month."" The program aims to raise awareness among expectant parents and the general public about the importance of preserving umbilical cord blood and priceless stem cells and is sponsored by the Parent's Guide to Cord Blood Foundation.
Additionally, estimations from the American Cancer Society from January 2022 stated that there were around 60,650 new instances of leukemia, 24,000 leukemia-related fatalities, and 11,450 deaths in the US from acute myeloid leukemia.
COVID-19 Impact Analysis
The COVID-19 pandemic has had a significant impact on the global cord blood banking services market due to travel restrictions and lockdowns. Cord blood banks also faced operational challenges in ensuring the safety of the staff, donors, and samples. Therefore, owing to the above factors, the cord blood banking services market is expected to be less affected over the forecast period.
Market Segmentation
By Bank Type
• Private
• Public
• Hybrid
By Component
• Cord Blood
• Placenta
By Application
• Cancers
• Blood disorders
• Genetic Disorders
• Neurologic Disorders
By End Users
• Hospitals
• Clinics
• Ambulatory Care
• Others
By Region
• North America
U.S.
Canada
Mexico
• Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
• South America
Brazil
Argentina
Rest of South America
• Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
• Middle East and Africa
Competitive Landscape
The major global players in the market include Cord Blood America, Inc., China Cord Blood Corporation, Cord Life Group Limited, Cryo-Cell International, Inc., Cryo-Save AG, ViaCord, Inc., California Cryo Bank Stem Cell Services LLC, Stem Cyte, Inc., Norton Healthcare, Inc., Lifeforce Cryo Bank Sciences Inc. among others.
Key Developments
• In September 2021, Cryoviva Singapore expanded cord blood banking services to Middle East, Bahrain.
Why Purchase the Report?
• To visualize the global cord blood banking services market segmentation based on bank type, component, application and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cord blood banking services market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.
The global cord blood banking services market report would provide approximately 85 tables, 88 figures, and 195 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies
- 1. Methodology and Scope
- 1.1. Research Methodology
- 1.2. Research Objective and Scope of the Report
- 2. Definition and Overview
- 3. Executive Summary
- 3.1. Snippet by Bank Type
- 3.2. Snippet by Component
- 3.3. Snippet by Application
- 3.4. Snippet by Region
- 4. Market Dynamics
- 4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.1.1. Increasing prevalence of genetic disorders
- 4.1.1.2. YY
- 4.1.2. Restraints
- 4.1.2.1. High cost associated with cord blood banking
- 4.1.2.2. YY
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis
- 5. Industry Analysis
- 5.1. Porter's Five Force Analysis
- 5.2. Supply Chain Analysis
- 5.3. Pricing Analysis
- 5.4. Regulatory Analysis
- 5.5. DMI Opinion
- 6. COVID-19 Analysis
- 6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
- 6.2. Pricing Dynamics Amid COVID-19
- 6.3. Demand-Supply Spectrum
- 6.4. Government Initiatives Related to the Market During Pandemic
- 6.5. Manufacturers Strategic Initiatives
- 6.6. Conclusion
- 7. By Bank Type
- 7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 7.1.2. Market Attractiveness Index, By Bank Type
- 7.2. Private*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 7.3. Public
- 7.4. Hybrid
- 8. By Component
- 8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 8.1.2. Market Attractiveness Index, By Component
- 8.2. Cord Blood*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 8.3. Placenta
- 9. By Application
- 9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
- 9.2. Cancers*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.3. Blood disorders
- 9.4. Genetic Disorders
- 9.5. Neurologic Disorders
- 10. By Region
- 10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
- 10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.2.6.1. U.S.
- 10.2.6.2. Canada
- 10.2.6.3. Mexico
- 10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.3.6.1. Germany
- 10.3.6.2. UK
- 10.3.6.3. France
- 10.3.6.4. Italy
- 10.3.6.5. Spain
- 10.3.6.6. Rest of Europe
- 10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.4.6.1. Brazil
- 10.4.6.2. Argentina
- 10.4.6.3. Rest of South America
- 10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
- 10.5.6.1. China
- 10.5.6.2. India
- 10.5.6.3. Japan
- 10.5.6.4. Australia
- 10.5.6.5. Rest of Asia-Pacific
- 10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Bank Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Component
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11. Competitive Landscape
- 11.1. Competitive Scenario
- 11.2. Market Positioning/Share Analysis
- 11.3. Mergers and Acquisitions Analysis
- 12. Company Profiles
- 12.1. Cord Blood America, Inc.
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
- 12.2. China Cord Blood Corporation
- 12.3. Cord life Group Limited
- 12.4. Cryo-Cell International, Inc.
- 12.5. Cryo-Save AG
- 12.6. ViaCord, Inc.
- 12.7. California Cryo bank Stem Cell Services LLC
- 12.8. Stem Cyte, Inc
- 12.9. Norton Healthcare, Inc.
- 12.10. Lifeforce Cryo bank Sciences Inc.
- LIST NOT EXHAUSTIVE
- 13. Appendix
- 13.1. About Us and Services
- 13.2. Contact Us
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook